Two Approaches to Cognitive Evaluation: Assessing the Strengths and Limitations of GPCOG and ACE-III
Introduction : The aging population highlights age as a key risk factor for dementia and other cognitive disorders. Reliable diagnostic tools are crucial. This review examines the Addenbrooke’s Cognitive Examination-III (ACE-III) and the General Practitioner Assessment of Cognition (GPCOG), focusin...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2025-02-01
|
| Series: | Journal of Education, Health and Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/57572 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction : The aging population highlights age as a key risk factor for dementia and other cognitive disorders. Reliable diagnostic tools are crucial. This review examines the Addenbrooke’s Cognitive Examination-III (ACE-III) and the General Practitioner Assessment of Cognition (GPCOG), focusing on their sensitivity, specificity, and utility in diverse healthcare contexts.
Purpose of Research: This analysis explores the clinical utility of the Addenbrooke’s Cognitive Examination-III (ACE-III) and the General Practitioner Assessment of Cognition (GPCOG) for diagnosing cognitive disorders, including dementia, emphasizing their use in primary care and specialized settings.
Materials and Methods : A review of 37 peer-reviewed studies, including clinical trials and validation research, was conducted using databases like PubMed and Google Scholar. Keywords included "GPCOG," "ACE-III," and "cognitive screening."
Results : ACE-III shows high diagnostic accuracy, with sensitivity and specificity exceeding 93% and 96%. It excels in assessing complex dementia but is time-intensive and requires trained personnel, limiting its use in primary care. Conversely, GPCOG is a quick, user-friendly tool suited for primary care but lacks the depth for detailed diagnostics.
Conclusions : ACE-III is optimal for detailed evaluations in specialized settings, while GPCOG excels in rapid primary care screening. Combined, they enhance early detection and management of cognitive disorders.
|
|---|---|
| ISSN: | 2391-8306 |